Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Nalan Akgül Babacan"'
Autor:
Tuğba AKIN TELLİ, Nalan AKGÜL BABACAN, Özkan ALAN, Mehmet Akif ÖZTÜRK, Rahib HASANOV, Sinan KOCA, Süleyman HALİL, Eda TANRIKULU ŞİMŞEK, Tuğba BAŞOĞLU, Özlem ERCELEP, Faysal DANE, Perran Fulden YUMUK
Publikováno v:
Namık Kemal Tıp Dergisi, Vol 10, Iss 1, Pp 74-79 (2022)
Aim:DR-70 is a newly developed immunoassay that detects fibrin degradation products in blood. We aimed to evaluate ability of DR-70 in monitoring treatment response in advanced gastrointestinal (GI) cancers.Materials and Methods:We prospectively enro
Externí odkaz:
https://doaj.org/article/0eecd9d0c2d943feb4b11316cac36178
Autor:
Tuğba Başoğlu, Kadriye Ebru Akar, Pelin Bağcı, Nalan Akgül Babacan, Mehmet Akif Öztürk, Fatih Emin Öztürk, Nazım Can Demircan, Rukiye Arıkan, Tuğba Akın Telli, Özlem Ercelep, Faysal Dane, Perran Fulden Yumuk
Publikováno v:
Balkan Medical Journal, Vol 39, Iss 1, Pp 12-20 (2022)
Background: Pancreatic ductal adenocarcinoma differs from other solid tumors with its unique immunosuppressive microenvironment and non-immunogenic feature. There are not many studies in the literature investigating the effect of these features on pr
Externí odkaz:
https://doaj.org/article/8851ad7ecb0946b8a21314805e33eb05
Autor:
Ozkan Alan, Tugba Akin Telli, Ozlem Ercelep, Eda Tanrikulu Simsek, Tugba Basoglu Tuylu, Aydan Mutis, Rahib Hasanov, Serap Kaya, Nalan Akgül Babacan, Faysal Dane, Perran Fulden Yumuk
Publikováno v:
Journal of Medical Case Reports, Vol 12, Iss 1, Pp 1-5 (2018)
Abstract Background Chordoma is a rare malignant tumor of the skull base and axial skeleton, with an incidence of less than 0.1/100,000 per year. Patients with advanced chordoma have a poor prognosis due to locoregional recurrence with infiltration a
Externí odkaz:
https://doaj.org/article/bab79c9c4ed4436996ff2f10859b7947
Autor:
Nalan Akgül Babacan
Publikováno v:
Journal of Oncological Sciences, Vol 2, Iss 1, Pp 5-6 (2016)
Immuno-oncology is a very popular field of medical science right now and developments on melanoma therapy have been absolutely marvelous for medical oncologists. Following these recent improvements, I remembered Irvin Yalom's novel “Schopenhauer Cu
Externí odkaz:
https://doaj.org/article/700a33383c9a4112b701266f27082314
Autor:
Salim YÜCE, Mehmet Metin ŞEKER, Sema KOÇ, İsmail Önder UYSAL, Turgut KAÇAN, Mehtap DOĞAN, Mansur DOĞAN, Nalan AKGÜL BABACAN, Saadettin KILIÇKAP
Publikováno v:
Turkish journal of medical sciences. 44(4)
WOS: 000336959100009
PubMed ID: 25551926
Background/aim: Oxaliplatin is an effective and widely used chemotherapeutic agent in the treatment of many solid tumors. The most common side effects are peripheral neuropathy, gastrointestinal toxi
PubMed ID: 25551926
Background/aim: Oxaliplatin is an effective and widely used chemotherapeutic agent in the treatment of many solid tumors. The most common side effects are peripheral neuropathy, gastrointestinal toxi
Autor:
Yun Song, John F Thompson, Frances A Collichio, Tasha Hughes, John Vetto, Dale Han, Jonathan Zager, Zeynep Eroglu, Jennifer Downs, David E Gyorki, Nikhil I Khushalani, Alexander van Akkooi, Georgia Beasley, Lisa Kottschade, Hidde M Kroon, Ann Lee, Norma E Farrow, Giorgos Karakousis, Michael Lowe, Avinash Sharma, Kristy K Broman, Amanda Nijhuis, Tina J Hieken, Jeffrey M Farma, Meghan Hotz, Jeremiah Deneve, Martin Fleming, Edmund K Bartlett, Lesly Dossett, Russell S Berman, Emma Stahlie, Jane Yuet Ching Hui, Marc Moncrieff, Jenny Nobes, Kirsten Baecher, Matthew Perez, David W Ollila, Roger Olofsson Bagge, Jan Mattsson, Harvey Chai, Jyri Teras, James Sun, Michael J Carr, Ankita Tandon, Nalan Akgul Babacan, Younchul Kim, Mahrukh Naqvi
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 8 (2022)
Until recently, most patients with sentinel lymph node-positive (SLN+) melanoma underwent a completion lymph node dissection (CLND), as mandated in published trials of adjuvant systemic therapies. Following multicenter selective lymphadenectomy trial
Externí odkaz:
https://doaj.org/article/5e2609c2e5e44274aabf900f1ff2c1c7
Autor:
Turgut Kaçan, Nalan Akgül Babacan, Birsen Yücel, Saadettin Kılıçkap, Ebru Atasever Akkaş, Mehmet Metin Şeker, Mehmet Fuat Eren, Ayfer Ay Eren
Publikováno v:
Volume: 35, Issue: 3 332-338
Cumhuriyet Medical Journal
Cumhuriyet Medical Journal
Aim. The purpose of this study is to examine the prognostic factors effecting the survival of stage IV non-small cell lung cancer patients. Method. Demographic, clinical and histopathologic data from 2006 to 2011 were collected from non-small cell lu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e78957e00ef973bce229f793e4affe40
https://hdl.handle.net/20.500.12418/2784
https://hdl.handle.net/20.500.12418/2784
Autor:
Özkan ALAN, Özlem ERCELEP, Tuğba AKİN TELLİ, Eda TANRIKULU ŞİMŞEK, Rahib HASANOV, Tuğba BASOGLU, Mehmet Akif ÖZTÜRK, Serap KAYA, Nalan AKGUL BABACAN, Tunç LAÇİN, Emine BOZKURTLAR, Faysal DANE, Perran Fulden YUMUK
Publikováno v:
Namık Kemal Tıp Dergisi, Vol 8, Iss 3, Pp 376-382 (2020)
Aim: Non-small cell lung cancer (NSCLC) accounts for 85% of all lung cancers. Although curative treatment is surgery in the early stages, disease relapse is common. In this study, we retrospectively evaluated the prognostic factors and outcomes of op
Externí odkaz:
https://doaj.org/article/3b461b5761e14dd396bd6eb9abbf448f
Autor:
Ozkan Alan, Tugba Akin Telli, Bilge Aktas, Sinan Koca, Ilker Nihat Ökten, Rahib Hasanov, Tugba Basoglu, Rukiye Arikan, Nazim Can Demircan, Ozlem Ercelep, Serap Kaya, Mustafa Umit Ugurlu, Handan Kaya, Nalan Akgul Babacan, Faysal Dane, Perran Fulden Yumuk
Publikováno v:
World Journal of Surgical Oncology, Vol 18, Iss 1, Pp 1-9 (2020)
Abstract Purpose Neoadjuvant chemotherapy is the standard front-line treatment modality in locally advanced breast cancer. Achieving pathological complete response (pCR) is a significant prognostic factor for prolonged disease-free and overall surviv
Externí odkaz:
https://doaj.org/article/9854984b8d9e4981ac56e556ec7b4c9c
Autor:
Inna Smalley, Eunjung Kim, Jiannong Li, Paige Spence, Clayton J. Wyatt, Zeynep Eroglu, Vernon K. Sondak, Jane L. Messina, Nalan Akgul Babacan, Silvya Stuchi Maria-Engler, Lesley De Armas, Sion L. Williams, Robert A. Gatenby, Y. Ann Chen, Alexander R.A. Anderson, Keiran S.M. Smalley
Publikováno v:
EBioMedicine, Vol 48, Iss , Pp 178-190 (2019)
Background: Melanoma is a heterogeneous tumour, but the impact of this heterogeneity upon therapeutic response is not well understood. Methods: Single cell mRNA analysis was used to define the transcriptional heterogeneity of melanoma and its dynamic
Externí odkaz:
https://doaj.org/article/7d086aa6efdb4ee5a9b2cf678b89c9e9